Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma
Abstract Our pathological study of a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma suggested that immune checkpoint inhibitor may be an effective therapy. The histological type is an important factor in determining treatment choices.
Bibliographic Details
| Main Authors: |
Ginji Omori,
Takahiro Osuga,
Koji Miyanishi,
Kota Hamaguchi,
Shingo Tanaka,
Hiroyuki Ohnuma,
Kazuyuki Murase,
Kohichi Takada,
Minoru Nagayama,
Yasutoshi Kimura,
Ichiro Takemasa,
Yasuhiro Kikuchi,
Toshihiko Torigoe,
Junji Kato |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
Wiley
2021-09-01
|
|---|
| Series: | Clinical Case Reports
|
|---|
| Subjects: |
|
|---|
| Online Access: | https://doi.org/10.1002/ccr3.4764
|
|---|
